C/EBPβ protein and DNA binding activity are increased in cardiac hypertrophy, and downregulation of C/EBPβ attenuates phenylephrine (PE)-induced cardiomyocyte hypertrophy 9, 10. Here, CEBPB is linked to hypertrophy.